Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11084832 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

Patent 11084832 was granted and assigned to Gilead Sciences on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110848320

Patent Inventor Names

Hang Chu0

Hongyan Guo0

Hyung-Jung Pyun0

Jennifer R. Zhang0

Jiayao Li0

Lan Jiang0

Michael L. Mitchell0

Nathan D. Shapiro0

...

Date of Patent

August 10, 2021

Patent Application Number

202003200

Date Filed

March 20, 2020

Patent Citations Received

‌

US Patent 12122776 Tetracyclic compounds and uses thereof

‌

US Patent 11787825 Therapeutic compounds for HIV virus infection

‌

US Patent 11944611 Capsid inhibitors for the treatment of HIV

‌

US Patent 12024528 Bridged tricyclic carbamoylpyridone compounds and uses thereof

‌

US Patent 12084467 Therapeutic compounds for HIV virus infection

Patent abstract

Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11084832 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API